Press releases

PROMUS Stent joins market-leading TAXUS® Paclitaxel-Eluting Coronary Stent Systems

Results expected to continue to support safety and performance of Boston Scientific's second-generation drug-eluting stent system

Company also to host WCC symposia on drug-eluting stents, therapies in cardiac rhythm management and carotid artery disease

"The second quarter was a transforming one for Boston Scientific," said Jim Tobin, President and CEO

Precision™ SCS System, the first and smallest rechargeable system, achieves rapid adoption

Initial six-month results consistent with previous TAXUS registries

New system enhances diagnosis and treatment of blocked vessels and heart disorders

New Jaw Configuration Designed to Yield Larger Tissue Specimens and Improve Procedural Outcomes

Young will be responsible for all quality assurance and reliability functions for the CRM Group, including product performance reporting

A live webcast and replay of the Thursday, July 27 conference call will be available

Report analyzed data from nearly 23,000 U.S. patents and 9,000 U.S. patent applications

Company is providing safety information and retrieving a specific subset of pacemakers, cardiac resynchronization pacemakers and implantable cardioverter defibrillators

A live webcast and replay of the June 27 conference session will be available

Jury had found that J&J's Cypher® stent product infringed a Boston Scientific drug coating patent

Boston Scientific's TAXUS stent system used in more complex lesions than J&J's Cypher

A live webcast and replay of the June 13 conference session will be available

Company plans to use the net offering proceeds for general corporate purposes

Company expects to receive the offering proceeds upon closing on June 9, 2006

Technology features powerful combination of deliverability and trackability to enhance clinical versatility

Rio™ Aspiration Catheter is indicated for use in the removal of thrombi, or clots, from vessels throughout the body

In upholding the trial court, the Court of Appeals agreed that Boston Scientific's products were not within the scope of the Medtronic patents

Researchers say novel visualization capability may reduce common need for repeat procedures

Trial advances understanding of dual-chamber pacing for patients at risk of sudden cardiac death

LATITUDE® Patient Management System aligns closely with recent ACC/AHA guidelines on managing heart failure

Physician society draft recommendations reinforce LATITUDE Active Monitoring ™ capabilities